iOnctura is a biopharmaceutical company focused on developing high impact, low disruption therapies for hard-to-treat cancers
iOnctura is a biopharmaceutical company focused on developing high impact, low disruption therapies for hard-to-treat cancers. The company aims to disrupt the tumor-stroma-immune interface to create more effective and less toxic treatments.